Search Results

CYT387 200mg  | 98.7%

APEXBIO TECHNOLOGY LLC

JAK-1/-2 inhibitor,ATP competitive Chromatin/Epigenetics|JAK

More Information Supplier Page

×

CYT387

AZ 960 1mg  | 98%

APEXBIO TECHNOLOGY LLC

JAKs inhibitor Chromatin/Epigenetics|JAK

More Information Supplier Page

×

AZ 960

AZ 960 5mg  | 98%

APEXBIO TECHNOLOGY LLC

JAKs inhibitor Chromatin/Epigenetics|JAK

More Information Supplier Page

×

AZ 960

CYT387 5mg  | 98.7%

APEXBIO TECHNOLOGY LLC

JAK-1/-2 inhibitor,ATP competitive Chromatin/Epigenetics|JAK

More Information Supplier Page

×

CYT387

CYT387 Evaluation Sample  | 98.7%

APEXBIO TECHNOLOGY LLC

JAK-1/-2 inhibitor,ATP competitive Chromatin/Epigenetics|JAK

More Information Supplier Page

×

CYT387

CYT387 10mM (in 1mL DMSO)  | 98.7%

APEXBIO TECHNOLOGY LLC

JAK-1/-2 inhibitor,ATP competitive Chromatin/Epigenetics|JAK

More Information Supplier Page

×

CYT387

Baricitinib (LY3009104, INCB028050) 200mg  | 98.06%

APEXBIO TECHNOLOGY LLC

JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK

More Information Supplier Page

×

Baricitinib (LY3009104, INCB028050)

Baricitinib (LY3009104, INCB028050) 50mg  | 98.06%

APEXBIO TECHNOLOGY LLC

JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK

More Information Supplier Page

×

Baricitinib (LY3009104, INCB028050)

WP1066 10mg  | 99.84%

APEXBIO TECHNOLOGY LLC

JAK2/STAT3 inhibitor,cell-permeable Chromatin/Epigenetics|JAK

More Information Supplier Page

×

WP1066

WP1066 25mg  | 99.84%

APEXBIO TECHNOLOGY LLC

JAK2/STAT3 inhibitor,cell-permeable Chromatin/Epigenetics|JAK

More Information Supplier Page

×

WP1066